Top Pharmaceuticals companies in Australia by Shareholders' Equity

This ranking features the top 14 Pharmaceuticals companies in Australia ranked by Shareholders' Equity, totaling a Shareholders' Equity of USD 28.28 B, for February 07, 2025.
#
Name
Shareholders' Equity
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 17.33 B
June 30, 2024 USD 169.95 -0.56%

Australia

2
USD 5.28 B
June 30, 2024 USD 17.72 0.58%

Australia

3
USD 1.64 B
June 30, 2024 USD 23.31 1.44%

Australia

4
USD 1.53 B
Sept. 30, 2024 USD 2.40 4.17%

Australia

5
USD 693.90 M
June 30, 2024 USD 0.87 -0.82%

Australia

6
USD 571.82 M
Jan. 31, 2024 USD 1.77 0.62%

Australia

7
USD 480.36 M
June 30, 2024 USD 1.90 -4.74%

Australia

8
USD 302.83 M
June 30, 2024 USD 2.89 2.85%

Australia

9
USD 135.36 M
June 30, 2024 USD 7.27 0.71%

Australia

10
USD 126.37 M
June 30, 2024 USD 2.09 0.97%

Australia

11
USD 101.41 M
Dec. 31, 2023 USD 18.33 -0.84%

Australia

12
USD 48.09 M
June 30, 2024 USD 1.23 -0.40%

Australia

13
USD 21.97 M
Dec. 31, 2023 USD 1.45 -3.95%

Australia

14
USD 19.48 M
Dec. 31, 2023 USD 6.16 2.82%

Australia

Frequently Asked Questions
  • Which Pharmaceuticals company in Australia has the highest Shareholders' Equity ?

    The Pharmaceuticals company in Australia with the highest Shareholders' Equity is CSL Limited (ASX: CSL.AX) at USD 17.33 B.

  • Which Pharmaceuticals company in Australia has the lowest Shareholders' Equity ?

    The Pharmaceuticals company in Australia with the lowest Shareholders' Equity is Anteris Technologies Ltd (ASX: AVR.AX) at USD 19.48 M.

SV Wall Street